ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice
Open Access
- 1 February 1998
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 39 (2) , 313-321
- https://doi.org/10.1016/s0022-2275(20)33893-1
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Premature Atherosclerosis in Patients with Familial Chylomicronemia Caused by Mutations in the Lipoprotein Lipase GeneNew England Journal of Medicine, 1996
- Intravenous Injection of Rabbit Apolipoprotein A-I Inhibits the Progression of Atherosclerosis in Cholesterol-Fed RabbitsArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse.Proceedings of the National Academy of Sciences, 1994
- Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice.Journal of Clinical Investigation, 1994
- Atherosclerosis and plasma and liver lipids in nine inbred strains of miceLipids, 1993
- Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AINature, 1991
- Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit.Journal of Clinical Investigation, 1990
- Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosisAmerican Heart Journal, 1987
- A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family.Journal of Clinical Investigation, 1980
- PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASEThe Lancet, 1975